Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy.
The 10th International Conference on Differentiation Therapy was held between April 29 and May 3, 2004, in Shanghai, China. In the tradition of previous conferences from this series, which have been held biannually since the first meeting organized 20 years ago by Samuel Waxman and Giovanni Rossi in Sardinia, the organizers of the 10th International Conference on Differentiation Therapy aimed to gather basic and clinical cancer investigators in a setting of plenary sessions, workshops, and poster presentations to maximize the effective exchange of information and foster the establishment of collaborative interactions. Approximately 300 scientists attended the meeting with a mission to discuss targeted approaches to cancer treatment, which stem from our understanding of basic biological processes and the mechanisms of their deregulation during tumorigenesis.
Zelent
Arthur
A
Section of Haematological Oncology, Institute of Cancer Research, London, United Kingdom.
Petrie
Kevin
K
Chen
Zhu
Z
Lotan
Reuben
R
Lübbert
Michael
M
Tallman
Martin S
MS
Ohno
Ryuzo
R
Degos
Laurent
L
Waxman
Samuel
S
D017209:Apoptosis / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D014212:Tretinoin / Q000627:therapeutic use
D014212:Tretinoin